Efficacy and Safety,Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.
This study has been completed.
Information provided by (Responsible Party):
First received: September 13, 2005
Last updated: October 16, 2012
Last verified: October 2012
The purpose of this long-term study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.
|Study Design:||Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Phase3,Open-Label,Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.|
Resource links provided by NLM:
Genetics Home Reference related topics: succinic semialdehyde dehydrogenase deficiency Wilson diseaseU.S. FDA Resources
Further study details as provided by Nobelpharma:
Primary Outcome Measures:
- Safety [ Time Frame: During study period (up to 96W ) ] [ Designated as safety issue: Yes ]
|Study Start Date:||March 2005|
|Study Completion Date:||January 2009|
|Primary Completion Date:||April 2008 (Final data collection date for primary outcome measure)|
Contacts and Locations